Inhibition of classical complement activation attenuates liver ischaemia and reperfusion injury in a rat model

Clinical and Experimental Immunology

Volumn 143, Issue 1, 2006, Pages 15-23

  Heijnen, B H M ^a   Straatsburg, I H ^a   Padilla, N D ^b   Van Mierlo, G J ^b   Hack, C E ^b,c   Van Gulik, T M ^a,d  

^a ACADEMIC MEDICAL CENTER   (Netherlands)

^b SANQUIN RESEARCH   (Netherlands)

^c VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^d UNIVERSITY OF AMSTERDAM   (Netherlands)

Author keywords

Classical complement; Inhibition; Liver ischaemia; Rat model; Reperfusion injury

Indexed keywords

ALANINE AMINOTRANSFERASE; ALBUMIN; C REACTIVE PROTEIN; COMPLEMENT COMPONENT C1S INHIBITOR; COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; COMPLEMENT MEMBRANE ATTACK COMPLEX; HUMAN ALBUMIN; BIOLOGICAL MARKER; COMPLEMENT; COMPLEMENT COMPONENT C3A; COMPLEMENT COMPONENT C4A; GLYCOPROTEIN; SC5B 9 PROTEIN COMPLEX; SC5B-9 PROTEIN COMPLEX;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BILE SECRETION; BODY WEIGHT; COMPLEMENT CLASSICAL PATHWAY; COMPLEMENT INHIBITION; COMPLEMENT SYSTEM; CONTROLLED STUDY; DRUG EFFECT; IMMUNOHISTOCHEMISTRY; LIVER CELL; LIVER ISCHEMIA; LIVER PROTECTION; MALE; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN LOCALIZATION; RAT; REPERFUSION INJURY; ANIMAL; BILE; BLOOD; CYTOCHEMISTRY; DRUG ADMINISTRATION; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; ISCHEMIA; LIVER; METHODOLOGY; PATHOPHYSIOLOGY; SECRETION; VASCULARIZATION; WISTAR RAT;

ALANINE TRANSAMINASE; ANIMALS; BILE; BIOLOGICAL MARKERS; C-REACTIVE PROTEIN; COMPLEMENT C1 INHIBITOR PROTEIN; COMPLEMENT C3A; COMPLEMENT C4A; COMPLEMENT PATHWAY, CLASSICAL; COMPLEMENT SYSTEM PROTEINS; DRUG ADMINISTRATION SCHEDULE; ENZYME-LINKED IMMUNOSORBENT ASSAY; GLYCOPROTEINS; HISTOCYTOCHEMISTRY; ISCHEMIA; LIVER; MALE; RATS; RATS, WISTAR;

EID: 33644821741     PISSN: 00099104     EISSN: 13652249     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2005.02958.x     Document Type: Article

References (48)

1. Vakeva A Laurila P Meri S Regulation of complement membrane attack complex formation in myocardial infarction Am J Pathol 1993 143 65 75
2. Weisman HF Bartow T Leppo MK et al. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis Science 1990 49 146 51
3. Yasuda M Takeuchi K Hiruma M et al. The complement system in ischemic heart disease Circulation 1990 81 156
4. Hill J Lindsay TF Ortiz F Yeh CG Hechtman HB Moore FDJ Soluble complement receptor type 1 ameliorates the local and remote organ injury after intestinal ischemia-reperfusion in the rat J Immunol 1992 149 1723 8
5. Hebert LA Cosio FG Birmingham DJ The role of the complement system in renal injury Seminars Nephrol 1992 12 408 27
6. Jaeschke H Pathophysiology of hepatic ischemia-reperfusion injury: The role of complement activation Gastroenterology 1994 107 583 6
7. Chavezcartaya RE Pinodesola G Wright L Jamieson NV White DJ Regulation of the complement cascade by soluble complement receptor type 1 Transplantation 1995 59 1047 52
8. Jaeschke H Farhood A Smith CW Contribution of complement-stimulated hepatic macrophages and neutrophils to endotoxin-induced liver injury in rats Hepatology 1994 19 973 9
9. Chan RK Ibrahim SI Verna N Carroll M Moore FD Jr. Hechtman HB Ischaemia-reperfusion is an event triggered by immune complexes and complement Br J Surg 2003 90 1470 8
10. Straatsburg IH Boermeester MA Wolbink GJ et al. Complement activation induced by ischemia-reperfusion in humans: a study in patients undergoing partial hepatectomy J Hepatol 2000 32 783 91
11. Meyer zu Vilsendorf A Link C Jorns A Nagel E Kohl J Preconditioning with the prostacyclin analog epoprostenol and cobra venom factor prevents reperfusion injury and hyperacute rejection in discordant liver xenotransplantation Xenotransplantation 2001 8 41 7
12. Bergamaschini L Gobbo G Gatti S et al. Endothelial targeting with C1-inhibitor reduces complement activation in vitro and during ex vivo reperfusion of pig liver Clin Exp Immunol 2001 126 412 20
13. Aderem A Underhill DM Mechanisms of phagocytosis in macrophages Annu Rev Immunol 1999 17 593 623
14. Jaeschke H Farhood A Bautista AP Spolarics Z Spitzer JJ Complement activates Kupffer cells and neutrophils during reperfusion after hepatic ischemia Am J Physiol 1993 264 G801 G809
15. Tokuka A Tanaka A Kitai T et al. Interrelationship of oxygen supply by hepatic artery and portal vein: rapid analysis of ischemia-reflow-induced changes in hepatic oxygenation in experimental and clinical subjects by tissue near- infrared spectroscopy Eur Surg Res 1994 26 342 52
16. Wakabayashi H Miyauchi A Karasawa Y Hamamoto I Maeba T Tanaka S Effect of warm ischemia and reperfusion injury on inducing major histocompatibility complex antigens on hepatocytes and nonparenchymal cells in the rat liver Transplant Proc 1993 25 3205 7
17. Thijs LG Hack CE Strack Van Schijndel RJ et al. Activation of the complement system during immunotherapy with recombinant IL-2. Relation to the development of side effects J Immunol 1990 144 2419 24
18. Rossen RD Swain JL Michael LH Weakly S Giannini E Entman ML Selective accumulation of the first component of complement and leukocytes in ischemic canine heart muscle. A possible initiator of an extramyocardial mechanism of ischemic injury Circulation Res 1985 57 119 30
19. Rossen RD Michael LH Kagiyama A et al. Mechanism of complement activation following coronary artery occlusion: evidence that myocardial ischemia in dogs causes release of constituents of myocardial subcellular origin that complex with human C1q in vivo Circulation Res 1988 62 572 84
20. Vogt W Hesse D Activation of the fifth component of human complement by oxygen-derived free radicals, and by methionine oxidizing agents: a comparison Immunobiology 1992 184 384 91
21. Vogt W von Damerau BZI Nolte R Brunahl D Non-enzymic activation of the fifth component of human complement, by oxygen radicals. Some properties of the activation product, C5b-like C5 Mol Immunol 1989 26 1133 42
22. Lehmann TG Koeppel TA Munch S et al. Impact of inhibition of complement by sCR1 on hepatic microcirculation after warm ischemia Microvasc Res 2001 62 284 92
23. Caliezi C Wuillemin WA Zeerleder S Redondo M Eisele B Hack CE C1-Esterase inhibitor: an anti-inflammatory agent and its potential use in the treatment of diseases other than hereditary angioedema Pharmacol Rev 2000 52 91 112
24. Jansen PM Eisele B de Jong IW et al. Effect of C1 inhibitor on inflammatory and physiologic response patterns in primates suffering from lethal septic shock J Immunol 1998 160 475 84
25. Buerke M Murohara T Lefer AM Cardioprotective effects of a C1 esterase inhibitor in myocardial ischemia and reperfusion [see comments] Circulation 1995 91 393 402
26. Buerke M Prufer D Dahm M Oelert H Meyer J Darius. Blocking of classical complement pathway inhibits endothelial adhesion molecule expression and preserves ischemic myocardium from reperfusion injury J Pharmacol Exp Ther 1998 286 429 38
27. Horstick G Heimann A Gotze O et al. Intracoronary application of C1 esterase inhibitor improves cardiac function and reduces myocardial necrosis in an experimental model of ischemia and reperfusion Circulation 1997 95 701 8
28. Hack CE Ogilvie AC Eisele B Jansen PM Wagstaff J Thijs LG Initial studies on the administration of C1-esterase inhibitor to patients with septic shock or with a vascular leak syndrome induced by interleukin-2 therapy Prog Clin Biol Res 1994 388 335 57
29. Horstick G Berg O Heimann A et al. Application of C1-esterase inhibitor during reperfusion of ischemic myocardium: dose-related beneficial versus detrimental effects Circulation 2001 104 3125 31
30. Lehmann TG Heger M Munch S Kirschfink M Klar E In vivo microscopy reveals that complement inhibition by C1-esterase inhibitor reduces ischemia/reperfusion injury in the liver Transpl Int 2000 13 S547 S550
31. Hack CE Wolbink GJ Schalkwijk C Speijer H Hermens WT Van den Bosch H A role for secretory phospholipase a(2) and c-reactive protein in the removal of injured cells Immunol Today 1997 18 111 5
32. Heijnen BH Elkhaloufi Y Straatsburg IH Van Gulik TM Influence of acidosis and hypoxia on liver ischemia and reperfusion injury in an in vivo rat model J Appl Physiol 2002 93 319 23
33. Heijnen BH van Veen SQ Straatsburg IH Van Gulik TM Pronounced effect of minor changes in body temperature on ischemia and reperfusion injury in rat liver J Appl Physiol 2001 91 265 8
34. de Smet BJ de Boer JP Agterberg J Rigter G Bleeker WK Hack CE Clearance of human native, proteinase-complexed, and proteolytically inactivated C1-inhibitor in rats Blood 1993 81 56 61
35. Nuijens JH Huijbregts CC Eerenberg-Belmer AJ et al. Quantification of plasma factor XIIa-Cl(-)-inhibitor and kallikrein-Cl(-)-inhibitor complexes in sepsis Blood 1988 72 1841 8
36. Nuijens JH Huijbregts CC Cohen M et al. Detection of activation of the contact system of coagulation in vitro and in vivo: quantitation of activated Hageman factor-C-1-inhibitor and kallikrein-C-1-inhibitor complexes by specific radioimmunoassays Thromb Haemost 1987 58 778 85
37. Bos IG van Mierlo GJ Bleeker WK et al. The potentiation of human C1-inhibitor by dextran sulphate is transient in vivo: studies in a rat model Int Immunopharmacol 2001 1 1583 95
38. Dong J Pratt JR Smith RA Dodd I Sacks SH Strategies for targeting complement inhibitors in ischaemia/reperfusion injury Mol Immunol 1999 36 957 63
39. Griselli M Herbert J Hutchinson WL et al. C-reactive protein and complement are important mediators of tissue damage in acute myocardial infarction J Exp Med 1999 190 1733 40
40. Asghar SS Pasch MC Therapeutic inhibition of the complement system. Y2K Update Front Biosci 2000 5 E63 E81
41. Doherty JC McMillen MA Ischemic liver injury J Am College Surgeons 1998 186 606 7
42. Fadok VA Warner ML Bratton DL Henson PM CD36 is required for phagocytosis of apoptotic cells by human macrophages that use either a phosphatidylserine receptor or the vitronectin receptor (alpha v beta 3) J Immunol 1998 161 6250 7
43. Cooper NR Biology of the complement system. In: Gallin JI Snyderman R, eds Inflammation: Basic Principles and Clinical Correlates Philadelphia Lippincot 1999
44. Fleming KA Evidence-based cellular pathology The Lancet 2002 359 1149 50
45. Lagrand WK Niessen HW Wolbink GJ et al. C-reactive protein colocalizes with complement in human hearts during acute myocardial infarction Circulation 1997 95 97 103
46. de Beer FC Baltz ML Munn EA et al. Isolation and characterization of C-reactive protein and serum amyloid P component in the rat Immunology 1982 45 55 70
47. Diaz Padilla N Bleeker WK Lubbers YT et al. Rat C-reactive protein activates endogenous complement system Immunology 2003 109 564 71
48. Scoazec JY Delautier D Moreau A et al. Expression of complement- regulatory proteins in normal and UW-preserved human liver Gastroenterology 1994 107 505 16